TKT and glioblastoma: Among the clinical trials using HSV-1-tk, the safety and efficacy of HSV-1-tk (gene therapy) in combination with valacyclovir, radiotherapy and chemotherapy in newly diagnosed and recurrent glioblastoma multiforme and grade III astrocytoma are currently being investigated (NCT03596086, NCT03603405).